AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8913140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 2
Study 8913140 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 2
Study 8913140 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 2
Study 1958279 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (low-dose cyclosporin, azathioprine, methylprednisolone)
Number of subjects: 102
Study 1958279 — intervention group
Group type: COMPARATOR
Intervention: CyA plus MP (double drug combination)
Number of subjects: 102
Study 1958279 — intervention group
Group type: COMPARATOR
Intervention: Aza plus CyA (double drug combination)
Number of subjects: 102
Study 1958279 — intervention group
Group type: COMPARATOR
Intervention: Aza plus MP (double drug combination)
Number of subjects: 102
Study 6184564 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg)
Number of subjects: 19
Study 6184564 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 19
Study 6184564 — intervention group
Group type: COMPARATOR
Intervention: Captopril (1 mg/kg)
Number of subjects: 19
Study 6184564 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 19
Study 30565955 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention implemented in 6 schools for 1 year.
Number of subjects: 1889
Study 30565955 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 schools, no intervention).
Number of subjects: 1889
Study 30565955 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention.
Number of subjects: 1889
Study 27531122 — intervention group
Group type: EXPERIMENTAL
Intervention: Social importance
Number of subjects: 0
Study 27531122 — intervention group
Group type: EXPERIMENTAL
Intervention: Promising a reward
Number of subjects: 0
Study 27531122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both social importance and promising a reward
Number of subjects: 0
Study 27531122 — intervention group
Group type: COMPARATOR
Intervention: Standard prospective memory instructions (control condition)
Number of subjects: 0
Study 26031399 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound at 36 weeks' gestation
Number of subjects: 2586
Study 26031399 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound at 32 weeks' gestation
Number of subjects: 2586
Study 26031399 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Cesarean delivery for fetal distress
Number of subjects: 2586
Study 26031399 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal admission
Number of subjects: 2586
Study 26031399 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia
Number of subjects: 2586
Study 26031399 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbilirubinemia
Number of subjects: 2586
Study 24321403 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages for medication reminders and education
Number of subjects: 90
Study 24321403 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational text messages only
Number of subjects: 90
Study 24321403 — intervention group
Group type: COMPARATOR
Intervention: No text messages
Number of subjects: 90
Study 22206078 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064 nm Nd:YAG laser hair reduction
Number of subjects: 6
Study 22206078 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral axilla)
Number of subjects: 6
Study 20201481 — intervention group
Group type: EXPERIMENTAL
Intervention: New oral anticoagulants (direct thrombin inhibitors and direct factor Xa inhibitors)
Number of subjects: 0
Study 20201481 — intervention group
Group type: COMPARATOR
Intervention: Conventional anticoagulants (warfarin and low-molecular-weight heparins)
Number of subjects: 0
Study 17314693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (20 microg/kg/min)
Number of subjects: 106
Study 17314693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (20 microg/kg/min)
Number of subjects: 106
Study 17314693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (10 microg/kg/min)
Number of subjects: 106
Study 17314693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (10 microg/kg/min)
Number of subjects: 106
Study 17314693 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 106
Study 15083370 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded (UL) breathing conditions
Number of subjects: 7
Study 15083370 — intervention group
Group type: COMPARATOR
Intervention: Normal (CON) breathing conditions
Number of subjects: 7
Study 11435508 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-linolenic acid (GLA)
Number of subjects: 0
Study 11435508 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO)
Number of subjects: 0
Study 11435508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11435508 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-linolenic acid (ALNA)
Number of subjects: 0
Study 11435508 — intervention group
Group type: EXPERIMENTAL
Intervention: Arachidonic acid (ARA)
Number of subjects: 0
Study 11435508 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 0
Study 10399110 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg orally once daily (n = 119)
Number of subjects: 236
Study 10399110 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin 500 mg orally twice daily (n = 117)
Number of subjects: 236
Study 11271223 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 50
Study 11271223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 3354734 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session class in breast self-examination (BSE)
Number of subjects: 459
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised dynamic posturography (CDP)
Number of subjects: 220
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile vibrotactile posturography system
Number of subjects: 220
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation (VR) protocols
Number of subjects: 220
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed up and go test
Number of subjects: 220
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP scores
Number of subjects: 220
Study 30606112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertiguard scores
Number of subjects: 220
Study 28526048 — intervention group
Group type: COMPARATOR
Intervention: Injectable hydromorphone
Number of subjects: 202
Study 28526048 — intervention group
Group type: COMPARATOR
Intervention: Injectable diacetylmorphine
Number of subjects: 202
Study 25622303 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality foster care intervention
Number of subjects: 136
Study 23239048 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic mixture (2.5 × 10(9) CFU live bacteria including Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium longum, Enterococcus faecium, and 625 mg fructooligosaccharide) for 5 days
Number of subjects: 209
Study 23239048 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic mixture
Number of subjects: 209
Study 23239048 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional hydration therapy without synbiotic)
Number of subjects: 209
Study 21215482 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPER-BP intervention (intensive BP management strategy using valsartan-based therapy)
Number of subjects: 2157
Study 21215482 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2157
Study 18061128 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal urinary creatinine excretion data
Number of subjects: 507
Study 16941298 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion
Number of subjects: 253
Study 16941298 — intervention group
Group type: COMPARATOR
Intervention: Transfusion of unwashed wound drainage
Number of subjects: 253
Study 12942142 — intervention group
Group type: EXPERIMENTAL
Intervention: Procyclidine (15 mg)
Number of subjects: 13
Study 12942142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 10675222 — intervention group
Group type: EXPERIMENTAL
Intervention: London handicap scale (LHS)
Number of subjects: 323
Study 10675222 — intervention group
Group type: EXPERIMENTAL
Intervention: Unweighted London handicap scale (U‐LHS)
Number of subjects: 323
Study 10675222 — intervention group
Group type: COMPARATOR
Intervention: Standard weighted scoring of LHS
Number of subjects: 323
Study 9342133 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol pretreatment
Number of subjects: 18
Study 9342133 — intervention group
Group type: COMPARATOR
Intervention: No esmolol pretreatment (Control)
Number of subjects: 18
Study 8441428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose unilateral electroconvulsive therapy
Number of subjects: 96
Study 8441428 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose unilateral electroconvulsive therapy
Number of subjects: 96
Study 8441428 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bilateral electroconvulsive therapy
Number of subjects: 96
Study 8441428 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose bilateral electroconvulsive therapy
Number of subjects: 96
Study 8441428 — intervention group
Group type: COMPARATOR
Intervention: Combined bilateral groups
Number of subjects: 96
Study 8441428 — intervention group
Group type: COMPARATOR
Intervention: Bilateral therapy
Number of subjects: 96
Study 8441428 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 96
Study 8441428 — intervention group
Group type: COMPARATOR
Intervention: Patients who responded to therapy
Number of subjects: 96
Study 3954009 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective blanket and heated glycine 1.5% bladder irrigation solution
Number of subjects: 100
Study 3954009 — intervention group
Group type: COMPARATOR
Intervention: No reflective blanket and/or heated 1.5% glycine
Number of subjects: 100
Study 30321510 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized Tranexamic Acid (500 mg tid)
Number of subjects: 47
Study 30321510 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 47
Study 27676118 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 403
Study 27676118 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 403
Study 27676118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 24452705 — intervention group
Group type: EXPERIMENTAL
Intervention: Group memory rehabilitation programme (ten 1.5-hour sessions)
Number of subjects: 48
Study 24452705 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 48
Study 22588495 — intervention group
Group type: COMPARATOR
Intervention: 20mg of Methylphenidate (MPH)
Number of subjects: 29
Study 21280534 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/ml Mitomycin-C solution
Number of subjects: 48
Study 21280534 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline Solution
Number of subjects: 48
Study 21280534 — intervention group
Group type: COMPARATOR
Intervention: 3% Sodium Chloride
Number of subjects: 48
Study 17591527 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drug therapy (including ACE inhibitors and ARBs)
Number of subjects: 691
Study 17591527 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort Study participants
Number of subjects: 691
Study 17591527 — intervention group
Group type: COMPARATOR
Intervention: Individuals who declined to participate in the Cohort Study
Number of subjects: 691
Study 16318141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group I (Jianji and Shenshu acupoints)
Number of subjects: 120
Study 16318141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group II (acupoints at limbs)
Number of subjects: 120
Study 16318141 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 12175313 — intervention group
Group type: EXPERIMENTAL
Intervention: EMF exposure (900 MHz, pulsed with 217 Hz, 2 W)
Number of subjects: 40
Study 12175313 — intervention group
Group type: COMPARATOR
Intervention: Placebo exposure
Number of subjects: 40
Study 12175313 — intervention group
Group type: EXPERIMENTAL
Intervention: EMF exposure
Number of subjects: 40
Study 10221703 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (30 microg of ethinyl oestradiol and 0.15 mg of levonorgestrel per tablet)
Number of subjects: 200
Study 10221703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 8595506 — intervention group
Group type: EXPERIMENTAL
Intervention: AZT monotherapy
Number of subjects: 2
Study 8595506 — intervention group
Group type: EXPERIMENTAL
Intervention: AZT/ddI and AZT/ddC combination therapy
Number of subjects: 2
Study 8595506 — intervention group
Group type: EXPERIMENTAL
Intervention: AZT/3TC combination therapy
Number of subjects: 2
Study 2242846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (160 mg daily for 6 weeks)
Number of subjects: 60
Study 2242846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1233231 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 20 mg i.m. followed by diazepam 20 mg i.v.
Number of subjects: 32
Study 1233231 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg i.m. followed by diazepam 20 mg i.v.
Number of subjects: 32
Study 1233231 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbitone 1 mg/kg i.m. followed by i.v. saline
Number of subjects: 32
Study 1233231 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg and saline i.v.
Number of subjects: 32
Study 1233231 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 20 mg i.v.
Number of subjects: 32
Study 1233231 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsatisfactory premedication
Number of subjects: 32
Study 30856340 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body resistance training (RT) for 2 weeks (6 sessions) including leg press, leg curl, and leg extension exercises
Number of subjects: 28
Study 30856340 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 28723227 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine (mean final daily dose of 2.6 ± 1.1 mg, n=14)
Number of subjects: 34
Study 28723227 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=18)
Number of subjects: 34
Study 28723227 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine
Number of subjects: 34
Study 28723227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 25222798 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude intervention (writing work-related gratitude diaries twice a week for 4 weeks)
Number of subjects: 102
Study 25222798 — intervention group
Group type: EXPERIMENTAL
Intervention: Hassle intervention (writing work-related hassle diaries twice a week for 4 weeks)
Number of subjects: 102
Study 25222798 — intervention group
Group type: COMPARATOR
Intervention: Nil-treatment (no-diary group)
Number of subjects: 102
Study 23802638 — intervention group
Group type: EXPERIMENTAL
Intervention: Sixth-generation dental bonding agents (DBAs)
Number of subjects: 108
Study 23802638 — intervention group
Group type: EXPERIMENTAL
Intervention: Seventh-generation dental bonding agents (DBAs)
Number of subjects: 108
Study 23802638 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourth-generation dental bonding agents (DBAs)
Number of subjects: 108
Study 21561960 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleconference-delivered fatigue management program
Number of subjects: 190
Study 21561960 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 190
Study 17555901 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose Gd‐BOPTA (0.05 mmol/kg)
Number of subjects: 47
Study 17555901 — intervention group
Group type: COMPARATOR
Intervention: Gd‐BOPTA (0.1 mmol/kg)
Number of subjects: 47
Study 17056961 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp nerve block (SNB) with 10 mL of 0.9% saline and a 1:1 mixture of bupivacaine 0.5% and lidocaine 2%
Number of subjects: 50
Study 17056961 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.1 mg x kg(‐1) IV after dural closure
Number of subjects: 50
Study 14616449 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IGF‐1 levels
Number of subjects: 652
Study 14616449 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IGFBP‐3 levels
Number of subjects: 652
Study 11099280 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole)
Number of subjects: 12649
Study 11099280 — intervention group
Group type: COMPARATOR
Intervention: Conventional antipsychotics (usually haloperidol or chlorpromazine)
Number of subjects: 12649
Study 8820712 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of derivational suffixes
Number of subjects: 0
Study 8820712 — intervention group
Group type: EXPERIMENTAL
Intervention: Suffix productivity
Number of subjects: 0
Study 1479417 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg daily for one week (Group A)
Number of subjects: 25
Study 1479417 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg daily for two weeks (Group B)
Number of subjects: 25
Study 1479417 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study 6231893 — intervention group
Group type: EXPERIMENTAL
Intervention: Azapropazone 600 mg b.d.
Number of subjects: 18
Study 6231893 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg b.d.
Number of subjects: 18
Study 6231893 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study 31570180 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Number of subjects: 79
Study 31570180 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemented group
Number of subjects: 79
Study 29394919 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + iERT (N=100)
Number of subjects: 200
Study 29394919 — intervention group
Group type: COMPARATOR
Intervention: TAU only (N=100)
Number of subjects: 200
Study 27270841 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat therapy (40.5°C bath for 60 min/session, 4-5 times/week for 8 weeks)
Number of subjects: 20
Study 27270841 — intervention group
Group type: COMPARATOR
Intervention: Sham group (thermoneutral water immersion)
Number of subjects: 20
Study 25073732 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult anagram task
Number of subjects: 91
Study 25073732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor task
Number of subjects: 91
Study 25073732 — intervention group
Group type: COMPARATOR
Intervention: Easy anagram task
Number of subjects: 91
Study 22929458 — intervention group
Group type: EXPERIMENTAL
Intervention: Life! programme intervention group
Number of subjects: 92
Study 22929458 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 92
Study 19897338 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention with a cognitive behavioral orientation (n=20)
Number of subjects: 60
Study 19897338 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention with community stakeholders (n=22)
Number of subjects: 60
Study 19897338 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (n=18)
Number of subjects: 60
Study 19897338 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 60
Study 16555259 — intervention group
Group type: EXPERIMENTAL
Intervention: 3T MRI
Number of subjects: 7
Study 16555259 — intervention group
Group type: EXPERIMENTAL
Intervention: 3T multislice DIR PD-/T2-weighted images
Number of subjects: 7
Study 16555259 — intervention group
Group type: COMPARATOR
Intervention: 1.5T MRI
Number of subjects: 7
Study 16555259 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5T and 3T MRI
Number of subjects: 7
Study 12665974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 18
Study 12665974 — intervention group
Group type: COMPARATOR
Intervention: Normobaric hypoxia (NH)
Number of subjects: 18
Study 11191004 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% azelastine eye drops
Number of subjects: 307
Study 11191004 — intervention group
Group type: COMPARATOR
Intervention: 0.05% levocabastine eye drops
Number of subjects: 307
Study 11191004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 9169209 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative measures for 400 line drawings
Number of subjects: 400
Study 1468261 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily application of betamethasone dipropionate cream and either a water-in-oil based moisturizing cream or lotion
Number of subjects: 96
Study 1468261 — intervention group
Group type: COMPARATOR
Intervention: Twice daily application of betamethasone dipropionate cream
Number of subjects: 96
Study 4028806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen suppositories (2 X 100 mg) administered 1-hour pre-operatively
Number of subjects: 60
Study 4028806 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppositories administered 1-hour pre-operatively
Number of subjects: 60
Study 30674296 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical microporous polysaccharide hemospheres (MPH) applied to the surgical site
Number of subjects: 42
Study 30674296 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MPH application)
Number of subjects: 42
Study 29544694 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 56
Study 29544694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 25862566 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 685
Study 25862566 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal gastrectomy
Number of subjects: 685
Study 25862566 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (75 years or older)
Number of subjects: 685